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Abstract 
Objectives:  To assess the compliance of clinical commissioning groups (CCG) in 
England with the ENT-UK Rhinosinusitis commissioning guide produced in collaboration 
with the Royal College of Surgeons England and the National Institute of Clinical Excellence.  
We also aimed to assess the ease of accessibility of data from CCG’s. 
Design:Audit of compliance of English CCG’s with the ENT-UK rhinosinusitis 
commissioning guide.  
Setting: CCG’s in England 
Participants:  58 of the 221 CCG’s in England were included, chosen because they were the 
first CCG’s authorised by NHS England or alternately, the CCG’s forecast to have a deficit in 
their first year of operation.Their websites were reviewed; when information was not easily 
accessibly, a freedom of information request was submitted to the relevant CCG. 
Main outcome measures: Compliance with commissioning guidelines for 
rhinosinusitis. 
Results: 13% of CCG’s had restrictive referral criteria in place,largely unrelated to 
published evidence-based guidance. The routine use of multiple courses of oral steroids, 
prescription of antibiotics, CT scanningwithin primary care, and delaying referral for a year, 
prior to referral to a specialist were recommended against published advice. 
Conclusions: Restricting access to surgerymay contribute to poorer outcomes and a 
decrease in the patient’s quality of life.  This is against the NHS constitution and open to legal 
challenge.  We encourage all ENT surgeons to review policies of their local CCG and engage 
with commissioners to ensure that their patients have evidence-based care. 
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Introduction 
In 2009 a report commissioned by the Department of Health (DH) recommended that a £20 
billion reduction in National Health Service (NHS) spending be made by 2014.  It was 
suggested that one of the ways in which this would be achieved would be through a reduction 
in spending on non-essential procedures and operations.   In April 2011 a report published by 
the NHS audit commission summarised that reducing Primary Care Trusts (PCT)spending on 
‘low clinical value’ treatments, would save the NHS about £500 million annually.  It 
suggested that individual PCT’s identify ‘low clinical value’ treatments within their area and 
reduce spending on these2,3Common Otorhinolaryngology procedures such as tonsillectomy 
and insertion of ventilation tubes soon appeared on these lists, as there was a paucity of 
evidence at the timeto support their long-term effectiveness.  Unfortunately, lack of evidence 
to support effectiveness has widely been assumed to be equivalent to evidence of 
ineffectiveness. 
 
Commissioners within this old system have subsequently been criticised.   They have been 
condemned for ignoring both clinical evidence and published guidance,restricting access to 
necessary surgical proceduresas a cost-cutting exercise, aimed at making short-term savings 
within the NHS4.   There has also been variation in commissioning between PCT’s around the 
country, leading to a postcode lottery for access to surgical treatment locally.  This goes 
against the NHS constitution, which states that all patients should have equal access to 
treatment and the need for treatment must be based on individual clinical merit following 
discussion between a patient and their clinician5.  
 
2013 saw clinical commissioning groups (CCG’s) replace both Strategic health authorities 
and PCT’s, where clinicians, namely general practitioners, became responsible for 
commissioning local services for their patients.  The aim of commissioning, as set out by the 
Department of Health’s quality, innovation, productivity and prevention ‘Right Care’ 
program; is to provide the highest quality of care, within a safe and effective NHS, whilst 
delivering the best valuefor the whole population from this investment in healthcare6.  Under 
Right Care, the Royal College of Surgeons (RCS) and surgical specialty associations have 
worked to establish evidence based, value-based, commissioning guidelines, with 
participation from all stakeholders, for elective surgical procedures7. 
As part of this project, ENT-UK, representing ENT services in the United Kingdom, and the 
Royal College of Surgeons, have produced three high quality, evidence based, clinical 
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commissioning guidelines for Tonsillectomy, Otitis Media with Effusion (OME) and 
Rhinosinusitis.  These guidelines are accredited by the National Institute for Clinical 
excellence (NICE) and designed to not only provide CCG’s with evidence based 
commissioning advice, but aim to reduce the postcode lottery across the country and 
standardise the rates of surgical procedures carried out between different healthcare trusts.  
The Rhinosinusitis guidelines are based upon the most recent iteration of the European 
guidelines (EPOS) published in 20128. 
 
In July 2014, the RCS England, audited compliance amongst English CCG’s, for four 
common operations, hip replacement, tonsillectomy, inguinal hernia and OME, with their 
published commissioning guidance.  They found that despite clear and consistent guidelines, 
many local commissioners were still imposing arbitrary referral criteria for the surgical 
procedures listed andnational variation in commissioning of surgical services persisted4. 
 
The aforementioned Rhinosinusitis Commissioning guide was also published by ENT-UK in 
2013 as part of the ‘Right Care’ commissioning program, funded by NHS England.   Within 
this commissioning document, separate, high value care pathways are provided for use by 
primary care and secondary care physicians, managing patients suffering with rhinosinusitis1.  
Through this study, we aimed to assess compliance of CCG’s across England, with the 
primary care pathway within the ENT-UK Rhinosinusitis Commissioning guide, using the 
same criteria as those employed by the RCS England report discussed above4. 
 
Methodology 
Ethical Considerations; Not applicable 
In their report; ‘is access to surgery a postcode lottery’; the Royal College of Surgeons of 
England, analysed commissioning policies for fourcommonly performed surgical procedures.  
They looked at 58 of the 211 CCG’s in England.   The CCG’s chosen by them fell into two 
groups, named ‘wave 1’ and ‘deficit’.  Wave 1 consisted of the first 35 CCG’s authorized by 
NHS England and were chosen as they felt these would have the most developed 
commissioning plans in place.  The deficit group was made up of 24 CCG’s, forecast to have 
a deficit in their first year of operation.  They felt that these CCG’s were more likely to have 
restrictive referral criteria in place4. 
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For this study, we employed the same 58 CCG’s as the report published by the RCS.  The 
website for each individual CCG was browsed to identify any available published 
commissioning guidance for patients with Rhinosinusitis who may require Endoscopic Sinus 
Surgery.  If this information was not available on-line, a Freedom Of Information (FOI) 
request was submitted to the individual CCG.  The FOI requests were submitted in November 
2014.  For those CCG’s that did not respond to the FOI, a further request was submitted six 
weeks later in December 2014. A comprehensive list of these CCG’s may be found in 
appendix 1. 
The commissioning policies were collated and then audited against the ‘primary care 
guidance’ contained within the joint RCS &ENT-UK commissioning guide on 
Rhinosinusitis4.  The primary diagnostic and treatment criteria that should be performed in 
primary care, prior to referral to secondary care, contained within this document may be seen 
in Figure 1. 
 
For CCG’s with Rhinosinusitis commissioning policies in place, the‘Right Care Quality 
Dashboard’(http://www.rightcare.nhs.uk/index.php/resourcecentre/procedures-explorer-tool/, 
accessed 17/1/15)was searched to find the age and sex adjusted activity rates for surgery 
performed for Rhinosinusutis within their catchment. The methodology of the Dashboard is 
beyond the scope of this paper, but draws on Hospital Episode Statistics data and is validated 
by professional coding auditors to provide data on secondary care activity sorted into relevant 
conditions to support Value Based Commissioning. The mean adjusted rate of surgery for 
chronic Rhinosinusitis is 26.01/100,000 population. 
 
Figure 1 
Result 
Thirty-five of our selected fifty-eight CCG’s had detailed descriptions of their commissioning 
policies available to the public, on their website.  FOI requests were sent to the remaining 
twenty-three CCG’s (40%), where these policies were not freely available.  Six of these 
twenty-three failed to respond to two formal FOI requests and hence fifty-two CCG’s were 
included in the data analysis. 
Seven out of the fifty-two CCG’s (13%) have restricted referral criteria in place for chronic 
rhinosinusitis, and have ‘procedure of limited clinical effectiveness’ (PoLCE) policies in 
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place for the management of patients with rhinosinusitis.  These CCG’s are Kernow, 
Wokingham, North Hampshire, Barnet, Bury, Haringey and Islington. 
The ‘2013 Rhinosinusitis commissioning guide’ has not been acknowledged or used verbatim 
by any of the seven published PoLCE policies reviewed by us on CRS.   
Two CCG’s, Barnet and Haringey, adopt the ‘CRS in adults management scheme for primary 
care and non-ENT specialist’ pathway published within the ‘European Position paper on 
Rhinosinusitis and Nasal polyps, 2012’ (EPOS) with one modification8.  The time frame for 
referral to an ENT specialist in the EPOS document, following initiation of therapy is 4 
weeks, whilst both of these CCG’s have modified this to three months, adopted by them from 
them the ‘NICE clinical knowledge summary (CKS) for chronic sinusitis’ management 
pathway, available on NICE’s website9.   Islington CCG has also adopted the NICE CKS 
criteria. 
 
Four CCG’s do not provide advice on the diagnostic criteria essential on history and 
examination for the diagnosis of chronic rhinosinusitis, whilst a fifth one lists examination 
criteria that are not in-line with those listed within the RCS guidance.  The use of a Visual 
Analogue scale (VAS) to assess severity of disease is not advised by any CCG although 
Wokingham does suggest using the SNOT-22 patient reported outcome measure.  It does not 
provide a reference range for severity assessment when using this tool.  No CCG’s provide 
advice for the further investigation of allergic rhinitis and asthma. 
Six out of seven CCG’s suggest the use of intranasal saline irrigation and all seven of them 
suggest intranasal steroids, prescribed by the General Practitioner (GP), prior to referral to a 
specialist, which is in line with the RCS guidance.  Four CCG’s recommend that the GP 
prescribe the patients a course of antibiotics, with one insisting on 3 months of macrolide 
antibiotics being given to all patients with symptoms of sinusitis prior to specialist referral. 
This is not in line with guidance provided by the RCS, which clearly states that they do not 
recommend the use of antibiotics in primary care due to limited evidence of efficacy in 
unselected groups.  
The RCS recommends a trial of oral prednisolonefor 5-10 days followed by topical 
fluticasone drops if large nasal polyps are clearly visible.  It recommends that the patient be 
reviewed and referred if there is no improvement in symptoms or polyp size, after four weeks.  
Three CCG’s discuss this in their guidelines but contrary to advice, two of them suggest that 
the oral steroids be administered repeatedly, up to a total of three times, three months apart.  
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One of these two CCG’s goes on to state that patients may only be referred on to a specialist 
after a trial of treatment, including three courses of oral steroids, after a period of 12 months.  
2 CCG’s do not include a time frame for referral to a specialist and a further four state that 
referral may be made if little improvement is seen by the patient after three months of topical 
treatment, however they do not discuss symptom severity that may be necessary prior to 
referral. 
The national mean adjusted rate of surgical activity for chronic rhinosinusitis (CRS) is 
26.01.Five out of seven CCGs with PoLCE policies in place have activity rates for the first 
Quarter, 2014 – 2015, below the national mean, and 2 (those CCG’swith the most restrictive 
policies) have rates greater than 2 standard deviations below the national mean. These are true 
outliers, and the variation is significant.  
 
Table 1 
Discussion 
Synopsis of key findings 
A positive finding of this study was that eighty-seven percent of the fifty-eight CCG’s audited 
do not have restrictive referral criteria in place for patients within their local population 
suffering with rhinosinusitis.   
 
Thirteen percent of CCG’s did have POLCE policies in place for rhinosinusitis but 
disappointingly none had followed the rhinosinusitis commissioning guideline published in 
partnership between ENT-UK, the RCS England and NICE.  However, three out of these 
seven CCG’s had followed alternate high quality published evidence, servicing their local 
population with appropriate commissioning guidelines. 
The use of antibiotics within primary care or the prescription of more than one course of oral 
steroids, are not supported by the published guidance. Despite this, multiple CCG’s have 
included this practice within their commissioning guidelines, perhaps as a means to delay 
onward referral to a specialist.  Macrolides are recommended for selected patients with CRS 
without polyps by the EPOS guidelines8. A low grade of recommendation is made, reflecting 
the conflicting results of 2 randomised controlled trials (RCT) examining the effectiveness of 
long-term antibiotics, highlighting the further need for RCT’s10,11.  Macrolide antibiotics have 
an anti-neutrophillic, anti-inflammatory response, and may not be beneficial in patients with 
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predominantlyeosinophilic disease, which includes most patients with CRS and polyps. 
Without endoscopic examination, it is difficult to differentiate between phenotypes, or indeed 
confirm the diagnosis to be correct.  We must keep in mind, that one in two patients meeting a 
symptomatic definition of sinusitis will have both normal endoscopic and radiological 
findings. Thus, treating all patients presenting to primary care with symptoms suggestive of 
CRS cannot be supported by current evidence. Antibiotic resistance has been quoted at the 
‘biggest threat to European Health’12. In addition there are small but significant 
cardiovascular risks associated with long term macrolide antibiotics13. 
 
There is limited evidence and no specific guidelines to define the optimum dose and duration 
of systemic steroid treatment in patients with nasal polyps. However, studies have shown that 
once an initial trial of maximum medical treatment (MMT), including 7 days of oral 
prednisolone, have failed, disease specific symptom scores decline14. Insisting on three to 
fourrepeated courses of prednisilone over12 months before making a definitive diagnosis is 
not supported by the literature, and risks detrioration in the pateint’s quality of life while 
waiting for specialist referral, not to mention the potential for side-effects from thepotent 
systemic corticosteroids. 
 
Policies aimed to restrict accesswere further seen by the imposition of forced waiting times of 
a year prior to referral for more specialist treatment.  ‘Right Care’ has stated that a minimum 
duration of symptoms, or a specific threshold of severity should not be used to restrict access 
to care, and this minimum waiting period of a year clearly contravenes this6.Denying a patient 
early access to surgery, by imposing long waiting times prior to referral, may inversely 
impact on the outcome of the surgery; increase the risk of complications and negatively 
impact the patient’s quality of life.Recent work has shown that surgery within the first 12 
months of persistent symptoms, for those who have failed MMT, achieves greater reductions 
in disease specific symptoms, measured using the SNOT-22and post-operative healthcare 
utilization, both in terms of doctor visits and prescription medication usage, when compared 
with patients who have surgery at a later stage in their CRS disease15,16. 
Finally, while we are encouraged that CCGs are no longer recommendingplain X-ray imaging 
of the sinuses, we were disappointed to find that one CCG requires a CT scan prior to referral. 
The role of the CT scan is primarily to assist surgical dissection as in many cases the 
diagnosis is confirmed on endoscopic examination, and is normally only requested after 
MMT has failedor in complex cases (e.g. local complications, systemic disease). Use in 
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primary care will expose many patients to unnecessary radiation, waste resources, and if not 
readily available to ENT surgeons, may not even benefit those who require surgery. 
 
We may debate if the commissioning guidelines for rhinosinusitis should be adopted by every 
CCG within England. This would homogenise practice, eliminating variation in referral rates 
and hence eradicate the post-code lottery effect.  It would provide G.P’s with high quality, 
evidence based management guidelines, allowing for appropriatereferral, which may be at an 
earlier stage in their disease for some patients, but achieve a more cost-effective outcome.  
We have seen an unexplained decrease in the rates of sinus surgery in England and Wales 
between 2008 and 2012, based on hospital episode statistics (HES) data(Figure 2). We do not 
know whether this is due to improved medical management of patients with CRS, but it is 
likely that restrictions in referral have contributed.  
 
Figure 2 
Strengths of the study 
This is the first study to assess and discuss the implications of restrictive funding criteria 
amongst English CCG’s for patients with rhinosinusitis.  Seeing a specialist for an accurate 
diagnosis and early treatment is in a patients best interest and denying them this treatment, 
perhaps as a money saving exercise, is against the NHS constitution.  
Limitations of the study 
Only 58 CCG’s out of a total of 221 were analysed, hence providing a snapshot of practice 
around the country. 
Comparison with other studies 
There are no other published studies looking at this particular question. 
Clinical applicability of the study 
CCG’s are required by law to publish their local commissioning policies.  Despite this, forty 
percent of the CCG’s did not have this data freely available on-line, of which twenty five 
percent ignored two Freedom of Information requests when asked to supply this data.  A 
proportion of the reviewed policies are not evidenced based and open to legal challenge by 
patients.  This studyshould encourage all ENT surgeons to review the policies of their local 
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CCG and engage with commissioners to ensure that their patients have evidence-based access 
to care. 
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1. Diagnostic criteria should include two or more persistent symptoms for at least 12 
weeks, one of which should be nasal obstruction and/or discharge, and/or facial 
pain/pressure or anosmia.  Severity of symptoms should be assessed using a 10-
point visual analogue scale to categorise the disease into mild or moderate/severe. 
Anterior rhinoscopy should be performed to exclude neoplasia or diagnose large 
polyps.  Allergic rhinitis and asthma should be looked for and managed 
appropriately. 
2. Patients with suspected malignancy should be referred urgently using the 2 week 
wait referral pathway 
3. Plain sinus x-rays should not be used 
4. All patients should be offered saline irrigation and intranasal corticosteroids. 
Antibiotics are not recommended.  If large polyps are visible, oral prednisolone 
for 5-10 days, followed by topical nasal steroid drops for 4 weeks, may be used. 
5. Patients with moderate/severe symptoms, despite three months of topical therapy, 
or those with large polyps that have not responded to four weeks of treatment, 
should be referred for a specialist opinion. For those with mild symptoms, medical 
treatment may be continued in primary care 
6. Patients should be provided with written information and actively engaged in their 
treatment decisions. 
 
Figure 1;Rhinosinusitis Commissioning guide, Primary Care referral pathway1 
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Figure 2; declining rates of admission with polypectomy or sinus surgery, listed as 
primary procedure, on the Hospital Episode Statistics (HES) Website 
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RCS guidance Kernow Wokingham North 
Hampshire 
Barnet Bury Haringey Islington 
Clinical 
symptoms >12 
weeks 
No No no yes Yes Yes No 
Severity using 
VAS scores 
No Advise SNOT 
22 
no no no No No 
Anterior 
rhinoscopy 
findings 
No no no yes Along 
with 
facial 
palpatio
n 
Yes No 
Manage allergic 
rhinitis and 
asthma 
no no no no no No No 
Red flag 
symptoms 
yes yes no yes no Yes Yes 
Use Nasal saline 
irrigation 
yes yes yes yes yes Yes No 
Use intranasal 
steroids 
yes yes yes yes yes Yes Yes 
Antibiotics not 
recommended 
Recomm
end use 
– details 
not 
given 
Recommend 
use – details 
not given 
3 months of 
a macrolide 
no Recomm
end 
use– 
details 
not 
given 
No No 
If nasal polyps- 
single course of 
oral steroids for 
10/7, followed 
by nasal drops 
Yes Yes; but to be 
repeated three 
times at three 
monthly 
intervals prior 
to referral 
Yes; but to 
be repeated 
at three 
monthly 
intervals 
no no No No 
Refer to 
secondary care 
if 
moderate/severe 
symptoms after 
No  no Yes, after 
one year  
Yes, 
after 
three 
months 
Yes – 
no time-
frame 
given 
Yes, after 
three 
months 
Yes, after 
three 
months 
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three months of 
treatments 
Do not use sinus 
x-ray 
They 
suggest 
G.Ps 
arrange 
a CT 
scan for 
polyps 
no no no yes 
 
 
 
no no 
Age/sex 
standardized 
activity (100,000 
population) 
27.4 27.0 16.9* 24.6 24.9 15.7* 19.9 
 
Table 1; Summary of CCG PoLCE policy findings and their compliance with the RCS 
advanced surgical standards and ENT-UK commissioning guide; 2013 
 
 
Appendix 1;  
Clinical Commissioning Groups 
 
Barnet Basildon and Brentwood 
Bassetlaw Bedfordshire 
Blackpool Bury 
Calderdale  Cambridgeshire and Peterborough 
Cannock Chase Castle Point and Rochford 
Coastal West Sussex Croydon 
Cumbria Dudley 
East and North Hertfordshire East Leicestershire and Rutland 
East Riding East Staffordshire 
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East Surrey Eastbourne, Hailsham and Seaford 
Gloucestershire Great Yarmouth and Waveney 
Haringey Harrow 
Hillingdon Islington 
Kernow Kingston 
Leicester City Liverpool 
Luton Mid Essex 
Newbury and District North and West Reading 
North East Lincolnshire North Hampshire 
North Somerset North Staffordshire 
North Tyneside Oldham 
Oxfordshire Portsmouth 
Rotherham Sandwell and West Birmingham 
Shropshire Somerset 
South East Staffordshire and Seisdon 
Peninsular 
South Gloucestershire 
South Reading Stafford and Surrounds 
Stoke on Trent Wakefield 
Wandsworth Warrington 
Warwickshire North West Cheshire 
West Leicestershire Wokingham 
 
